Real-time enrollment status for this pik3ca overgrowth spectrum clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06789913 |
| Recruiting Status | Recruiting |
| Condition | PIK3CA Overgrowth Spectrum |
| Phase | Clinical Trial |
| Target Enrollment | 277 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Relay Therapeutics, Inc. |
| Last Updated on CT.gov | January 8, 2026 (Jan 8, 2026) |
As of March 2, 2026: Clinical trial NCT06789913 is currently recruiting participants. This clinical trial study for pik3ca overgrowth spectrum is actively seeking new participants at 9 locations across the United States. The study is sponsored by Relay Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06789913 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06789913 was last updated Jan 8, 2026 (January 8, 2026). HelloStudys verifies this status automatically.